Bioregenx (BRGX) Total Debt (2021 - 2026)

Bioregenx's Total Debt history runs 6 years deep, the most recent figure standing at $1.1 million for Q1 2026.

• In Q1 2026, Total Debt changed 0.25% year-over-year to $1.1 million; the TTM figure through Mar 2026 stood at $1.1 million (changed 0.25% YoY), while the FY2025 annual figure was $2.2 million, up 92.31% from the prior year.
• Total Debt was $1.1 million for Q1 2026 at Bioregenx, down from $2.2 million in the prior quarter.
• In the past five years, Total Debt ranged from a high of $2.2 million in Q4 2025 to a low of $200000.0 in Q4 2022.
• Historically, Total Debt has averaged $1.1 million across 5 years, with a median of $1.1 million in 2024.
• The sharpest annual moves came in 2024 and 2025: Total Debt jumped 875.61% in 2024, then plunged 38.45% in 2025.
• A 5-year view of Total Debt shows it stood at $200000.0 in 2022, then soared by 350.68% to $901362.0 in 2023, then grew by 26.24% to $1.1 million in 2024, then soared by 92.31% to $2.2 million in 2025, then tumbled by 48.12% to $1.1 million in 2026.
• The last three Total Debt figures came in at $1.1 million (Q1 2026), $2.2 million (Q4 2025), and $1.2 million (Q3 2025), per Business Quant data.